Addition of Bevacizumab to Temsirolimus in Kidney Cancer Patients

Publisher： Karger

E-ISSN： 1662-6575|4|3|531-533

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.3, 2011-11, pp. : 531-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Bevacizumab in Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 314-325

Karger

Access to resources Recommend Favorite

Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 27-38

Karger

Access to resources Recommend Favorite

Genetic variants in the renin–angiotensin system predict response to bevacizumab in cancer patients

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 12, 2015-12 ,pp. : 1325-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Temsirolimus in patients with advanced renal cell carcinoma: an overview

By Bhatia Shailender  

Advances in Therapy, Vol. 26, Iss. 1, 2009-01 ,pp. : 55-67

Springer Publishing Company

Access to resources Recommend Favorite

Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 153-159

Karger

Access to resources Recommend Favorite